BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10483680)

  • 1. [Treatment with Kava--the root to ocombat stress].
    Müller B; Komorek R
    Wien Med Wochenschr; 1999; 149(8-10):197-201. PubMed ID: 10483680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kava: a comprehensive review of efficacy, safety, and psychopharmacology.
    Sarris J; LaPorte E; Schweitzer I
    Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Piper methysticum (kava kava).
    Altern Med Rev; 1998 Dec; 3(6):458-60. PubMed ID: 9855570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
    Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kava-kava preparations--alternative anxiolytics].
    Nowakowska E; Ostrowicz A; Chodera A
    Pol Merkur Lekarski; 1998 Mar; 4(21):179-180a. PubMed ID: 9640076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum.
    Sarris J; Kavanagh DJ; Adams J; Bone K; Byrne G
    Complement Ther Med; 2009 Jun; 17(3):176-8. PubMed ID: 19398072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of kava in the treatment of anxiety disorders.
    Singh YN; Singh NN
    CNS Drugs; 2002; 16(11):731-43. PubMed ID: 12383029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kava.
    Harv Womens Health Watch; 1998 Aug; 5(12):6. PubMed ID: 9713242
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines.
    Malsch U; Kieser M
    Psychopharmacology (Berl); 2001 Sep; 157(3):277-83. PubMed ID: 11605083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health policy versus kava (Piper methysticum): Anxiolytic efficacy may be instrumental in restoring the reputation of a major South Pacific crop.
    Thomsen M; Schmidt M
    J Ethnopharmacol; 2021 Mar; 268():113582. PubMed ID: 33189846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the efficacy of the acetonic kava-kava extract WS1490 in patients with non-psychotic anxiety disorders.
    Witte S; Loew D; Gaus W
    Phytother Res; 2005 Mar; 19(3):183-8. PubMed ID: 15934028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial.
    Savage KM; Stough CK; Byrne GJ; Scholey A; Bousman C; Murphy J; Macdonald P; Suo C; Hughes M; Thomas S; Teschke R; Xing C; Sarris J
    Trials; 2015 Nov; 16():493. PubMed ID: 26527536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiolytic properties of Piper methysticum extract samples and fractions in the chick social-separation-stress procedure.
    Feltenstein MW; Lambdin LC; Ganzera M; Ranjith H; Dharmaratne W; Nanayakkara NP; Khan IA; Sufka KJ
    Phytother Res; 2003 Mar; 17(3):210-6. PubMed ID: 12672148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kava-kava and anxiety: growing knowledge about the efficacy and safety.
    Bilia AR; Gallon S; Vincieri FF
    Life Sci; 2002 Apr; 70(22):2581-97. PubMed ID: 12269386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kava-kava extract in anxiety disorders: an outpatient observational study.
    Scherer J
    Adv Ther; 1998; 15(4):261-9. PubMed ID: 10186945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kava (Piper methysticum).
    J Soc Integr Oncol; 2009; 7(4):170-2. PubMed ID: 19883532
    [No Abstract]   [Full Text] [Related]  

  • 17. Kava consumption and its health effects.
    Gounder R
    Pac Health Dialog; 2006 Sep; 13(2):131-5. PubMed ID: 18181402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kava treatment in patients with anxiety.
    Geier FP; Konstantinowicz T
    Phytother Res; 2004 Apr; 18(4):297-300. PubMed ID: 15162364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study.
    Sarris J; Byrne GJ; Bousman CA; Cribb L; Savage KM; Holmes O; Murphy J; Macdonald P; Short A; Nazareth S; Jennings E; Thomas SR; Ogden E; Chamoli S; Scholey A; Stough C
    Aust N Z J Psychiatry; 2020 Mar; 54(3):288-297. PubMed ID: 31813230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of kavalactones in dried kava (Piper methysticum) powder using near-infrared reflectance spectroscopy and partial least-squares regression.
    Gautz LD; Kaufusi P; Jackson MC; Bittenbender HC; Tang CS
    J Agric Food Chem; 2006 Aug; 54(17):6147-52. PubMed ID: 16910700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.